Adenomas of the pars intermedia from 19 horses and normal pituitary glands from seven horses were evaluated histologically and immunocytochemically for adrenocorticotropic hormone (ACTH), a-melanocyte-stimulating hormone (a-MSH), &endorphin (@-END), proopiomelanocortin (POMC), prolactin, neuron specific enolase, and glial fibrillary acidic protein (GFAP). The 26 horses ranged in age from 7 to 31 years. Histologically, all adenomas had a uniform pattern characterized by cords of large columnar cells forming palisades and pseudoacini separated by a delicate fibrovascular stroma. Immunostaining of adenomas derived from the pars intermedia was similar to that of non-neoplastic equine pars intermedia. An immunocytochemical evaluation revealed a diffuse, strong cytoplasmic reaction for POMC, a moderate to strong reaction for a-MSH and (3-END, a weak reaction for ACTH, and negative immunostaining for prolactin, GFAP, and neuron specific enolase in the adenomas. The unique clinicopathologic syndrome that develops in horses with pituitary adenomas appears to be the result of an over-production of POMC-derived peptides in addition to space-occupying effects resulting in dysfunction of the hypothalamus and neurohypophysis.
The clinical syndrome has been suggested to result largely from hypothalamic dysfunction secondary to compression and damage of the hypothalamo-neurohypophyseal tract by pituitary adenomas. These are able to extend suprasellarly because of the incomplete diaphragma sellae in h o r~e s .~J~ Other investigators interpret the functional disturbances associated with pituitary adenomas in horses to be a variant of Cushing's disease in human beings in which the tumors produce an excessive amounts of adrenocorticotropic hormone (ACTH).10,23 Elevated plasma proopiomelanocortin (P0MC)-derived peptides and cortisol levels, loss of the circadian rhythm of circulating cortisol levels, and resistance to negative feedback of glucocorticosteroids have been reported in horses with pituitary adenomas derived from the pars i n t e~-m e d i a .~~.~~.~~ Biochemical studies of adenomas derived from the pars intermedia in horses revealed a hormonal profile of POMC-derived peptides, including a-melanocyte-stimulating hormone (a-MSH), p-melanocyte-stimulating hormone (P-MSH), corticotropin-like intermediate lobe peptide (CLIP), and P-endorphin (@-END) in the tissue closely resembling that of the normal pars i~~t e r m e d i a .~~,~~ Post-translational processing of POMC differs between the pars intermedia and pars distalis in horse^,^^,^^ as well as in other s~e c i e s .~,~,~~,~~ In corticotrophs of the pars distalis, POMC is processed predominantly to ACTH, P-lipotropin, and variable amounts of y-lipotropin and P-END.5,8 ACTH is processed further in the pars intermedia to a-MSH and CLIP, and P-lipotropin that is cleaved to P-MSH and P-END-related pep tide^. ^^^ The purpose of this study is to characterize immunocytochemically adenomas derived from the pars intermedia in horses for POMC-derived peptides, prolactin, GFAP, and neuron specific enolase.
Materials and Methods
Adenomas of the pars intermedia were studied from the files ofthe Department ofveterinary Pathobiology, The Ohio State University (Columbus, OH) for horse Nos. 1-16. In addition, pituitaries from non-tumor-bearing (horse Nos. [20] [21] [22] [23] [24] [25] [26] and tumor-bearing (horse Nos. [17] [18] [19] horses (Table 1) of various ages and both sexes were collected at the Institut fur Veterinar-Pathologie, Justus-Liebig-Universitat, Gies- 
hyperplasia and hyperplasia sen. Table 1 summarizes the pertinent clinical data and necropsy findings of the horses included in the study. A complete necropsy was performed on all horses. Pituitary glands were removed, fixed in 4% neutral phosphatebuffered formalin or Bouin's solution, and embedded in paraffin. Sections of 5 to 7 pm were mounted and stained with hematoxylin and eosin, Masson's trichrome, and periodic acid-Schiff. Some of the formalin-fixed specimens (horse Nos. 1-6) were pretreated with protease type XXIV (Sigma, Deisenhofen, FRG) for 15 minutes. 29 For immunocytochemical staining, sections were processed according to the peroxidase-antiperoxidase (PAP) methodz9 as previously de~cribed.~ Briefly, sections were deparaffinized in xylene, rehydrated through graded alcohols, and washed in Tns-buffered saline (0.1 M Tris-base, 0.9% NaCI, pH 7.8). Endogenous peroxidase was blocked by 0.3% hydrogen peroxide in methanol for 30 minutes at room temperature. The sections were washed in Tris-buffered saline for 5 minutes and incubated with undiluted normal pig serum for 10 minutes at room temperature, followed by overnight incubation at 4 C with rabbit antisera to the following antigens: equine prolactin (anti-ePRL, #1-8, 1 : 600, Dr. C. L. Chen, University of Florida, Gainesville, FL);4 a-MSH (antia-MSH, 1 : 1,000, UCB Bioproducts, Brussels, Belgium); @ L -2 4 -~~r t i~~t r~p i n (anti-ACTH, 8 1/2, 1 : 2,250, Drs. M. Heinrichs and S. Blahser, Justus-Liebig-Universitat, Gie~sen);~ hlA8N-terminal of human POMC (anti-h148N-POMC, R 64-3, 1 : 500) and h1-76N-terminal of human POMC (anti-h'-76N-POMC, R 4 B 2, 1 :500, both from Dr. F. E. Estivariz, Universidad Nacional de La Plata, La Plata, Argentina);16 @-END (anti-@-END, 1 : 380, from UCB Bioproducts, Brussels, Belgium); neuron specific enolase (anti-NSE, 1 : 200, Dako, Hamburg, FRG); and GFAP (anti-GFAP, 1 : 1,000, Dako). The sections were incubated with pig anti-rabbit Ig (Dako, 1 : 40) as link antibody, followed by rabbit PAP complex (Dako, 1 : 100) for 30 minutes at room temperature in a moist chamber. All antibodies were diluted in Tris-buffered saline. Sections were thoroughly washed with Tris-buffered saline. The final reaction was developed in 0.05% 3,3'-diaminobenzidine tetrahydrochloride (DAB; Serva, Heidelberg, FRG). Some sections were lightly counterstained with hematoxylin. Controls included substitution of the primary antibody with normal rabbit serum or Tris-buffered saline, as well as omission of the link pig anti-rabbit Ig or the PAP complex.
Results

Macroscopic and histologic findings
Macroscopically, pituitary glands from 13 of the 26 horses were enlarged and had macroadenomas of the pars intermedia that replaced most of the pars distalis. Six pituitary glands contained microadenomas ( Table  1 ). The adenomas were sharply delineated without a definite capsule causing varying degrees of compression and atrophy of the pars distalis. In addition, they infiltrated and occasionally destroyed the pars nervosa by compression. Pituitary adenomas derived from the pars intermedia often were subdivided by fine connective tissue septae into several nodules composed of large columnar, spindle-shaped or polygonal cells. The tumor cells were arranged in cords forming palisades and pseudoacini that were intimately associated with a delicate fibrovascular stroma. Cuboidal cells occasionally formed follicular structures containing a colloid-like, periodic acid-Schiff positive material. The cytoplasm of tumor cells stained lightly acidophilic with hematoxylin and eosin, was chromophobic with trichrome stain, and weakly periodic acid-Schiff-positive. The nuclei were homogenous, round, and hyperchromatic with prominent nucleoli. Mitotic figures and areas of hemorrhage were infrequent.
The pituitary glands from the seven non-tumorbearing horses had no microscopic alterations except for microcyst formation in the pars distalis and pars intermedia.
Immunocytochemical findings
Approximately 10% of the cells in the normal equine pars distalis stained strongly with antibodies directed against proopiomelanocortin (POMC), adrenocorticotropic hormone (ACTH) and @-endorphin (@-END). The corticotrophs were oval to polygonal or occasionally stellate-shaped with long interdigitating processes. Corticotrophs usually occurred as single cells or occasionally in clusters in the rostra1 portion of the pars distalis. A small subset of corticotrophs interspersed Fig. 3 . Adenoma of pars intermedia with patchy immunostaining using anti-hi-48N-pr~~pi~melan~c~rtin. Fig. 4 . Adenoma of pars intermedia with moderate reaction for a-melanocyte-stimulating hormone. Fig. 5 . Adenoma of pars intermedia with moderate to strong staining for p-endorphin. within the pars distalis also stained with anti-a-MSH (a-melanocyte-stimulating hormone). A cell type distinct from the corticotrophs stained with anti-equine prolactin. Prolactin-positive cells were arranged mainly in groups and occurred in large numbers throughout the pars distalis. Cytoplasmic immunostaining either was diffuse or globular in the paranuclear region. Marked hyperplasia and focal hypertrophy of prolactin-positive cells were present in the pars distalis of one pregnant mare (Table I) .
Multifocal, mild to moderate, corticotroph hyperplasia was a frequent finding in the pars distalis of horses older than 9 years (Fig. 1) . These cells differed morphologically from the corticotrophs described above in pituitary glands of non-tumor-bearing horses. They were slender or elongated with spherical, eccentric nuclei.
Immunocytochemical evaluation of the normal equine pars intermedia using anti-h1-48N-POMC, anti-h1-76N-POMC, and anti-a-MSH revealed a strong cytoplasmic reaction in nearly all cells, whereas immunostaining for &END was diffuse and moderate in intensity with focal areas of marked reactivity. Most pars intermedia cells stained weakly to moderately for ACTH.
Adenomas derived from the pars intermedia (1 9 horses) had a uniform pattern of predominantly POMC immunoreactivity. The staining pattern obtained with anti-h1-48N-POMC and anti-h1-76N-POMC was identical, although staining intensity with the latter antibody was weaker. Both POMC antibodies had variations in staining intensity in different regions of the tumors (Figs. 2, 3) . All adenomas had moderate to strong, diffuse cytoplasmic staining for a-MSH ( Fig.   4 ) and P-END ( Fig. 5 ), whereas immunoreactivity for ACTH was more patchy and weak in staining and intensity (Fig. 6 ). Adenomas of the pars intermedia were negative for prolactin ( Fig. 7) , GFAP, and neuron specific enolase. A few GFAP-positive cells were observed in two adenomas that most likely represented residual glial cells of the pars nervosa ( Fig. 8) . A single adenoma (horse No. 18 ) had focal areas of immunoreactivity for neuron specific enolase. In general, immunostaining of the adenomas was less intense in formalin-fixed specimens compared to Bouin's-fixed pituitary tissue.
Although immunocytochemical evaluation of the remaining portion of pars distalis in horses with ade-nomas of the pars intermedia was made difficult by compression, the distribution of various peptides was similar to the normal pars distalis. Multinodular corticotroph hyperplasia of varying severity in the pars distalis was present in nine horses with pars intermedia-adenomas (Table 1 ).
Discussion
The results of this study provide support for the concept that horses with pituitary adenomas derived from the pars intermedia develop a unique clinical syndrome that is associated with the autonomous production of excess amounts of proopiomelanocortin (P0MC)-derived peptides. Immunocytochemical evaluation of adenomas of the pars intermedia revealed a diffuse moderate to strong staining for POMC, a-melanocyte-stimulating hormone (a-MSH), and pendorphin (&END). Although many of the functional disturbances in horses with pituitary adenomas (e.g., diabetes insipidus, polyphagia, hyperpyrexia, hyperhidrosis, and hirsutism) appear to be the result of hypothalamic or neurohypophyseal dysfunction, other behavorial signs (e.g., docility and diminished responsiveness to painful stimuli) may be related to the elevated plasma and cerebral spinal fluid levels of p-END.I9 Although adrenocorticotropic hormone (ACTH) was demonstrated in each adenoma of the pars intermedia, the staining intensity was patchy and considerably weaker than that of POMC, a-MSH, and 0-END. These findings are in accord with recent biochemical studies that reported markedly elevated concentrations of immunoreactive POMC and POMCderived peptides (including a-and P-MSH, corticotropin-like intermediate lobe peptide, and @-END) in adenomas and plasma of affected horses relative to ACTH. '9,21,33 The overall processing of peptides in adenomas of the pars intermedia appears to be similar to that in the normal equine pars intermedia. 19, 22, 33 This is consistent with the finding of similar patterns of immunostaining in the normal and neoplastic pars intermedia of horses in this study.
Corticotrophs in the pars distalis of all horses had strong immunostaining for ACTH, whereas only a few cells stained for a-MSH. Our immunocytochemical findings illustrate the differences between adenomas of the pars intermedia in horses and corticotroph adenomas of the pars distalis (also pars intermedia in dogs) that result in the classical Cushing's disease in human beings' ' , l 4 and the dog.24 Corticotroph adenomas in human beings and dogs associated with Cushing's disease are characterized by strong immunostaining for ACTH and weak to moderate immunostaining for High levels of plasma ACTH and/or adrenal cortical hyperplasia have been reported in some horses with pituitary adenomas. L0,20,21,23,33 Increased levels of plasma ACTH were believed to be caused by both increased biosynthetic capacity of the tumor cells and by an increase in the total number of ACTH-secreting cells. 33 In the present study, nodular or diffuse adrenal cortical hyperplasia was evident only in four horses with an adenoma of the pars intermedia (Table 1 ). This observation is consistent with the finding that most horses with pituitary adenomas had plasma cortisol levels in the normal range (unpublished observations) and had weak immunostaining for ACTH. Seven of 19 horses with pars intermedia-adenomas had bacterial and fungal infections. Similar findings have been reported by others in horses with pituitary adenomas2J0J xZ2 that were suggested to be a sequel of immunosuppression from the elevated plasma cortisol levels.20,21 The apparent increased incidence of bacterial or fungal infections in horses with pituitary adenomas may be related, in part, to the persistent hyperglycemia,2JoJs~22 similar to that observed in both human and animal patients with diabetes mellitus. Five of seven horses with pars intermedia-adenomas and concurrent bacterial and fungal infections had hyperglycemia.
Two antisera directed against different parts of the N-terminal fragment of human POMC differed in their immunoreactivity. Anti-h1-48N-POMC had stronger immunostaining of the tumor cells than antiserum to h1-76N-POMC. The significance of the differences in immunostaining of POMC-derived peptides and the specificity of the two antibodies generated against different portions the N-terminal fragment of human POMC in the horse is undetermined.
Reliable data on the incidence of pituitary adenomas in horses are not available, but, from our study and earlier report^,^^,^^ they appear to be more prevalent in older animals, with females affected more frequently than males. In addition, horses with adenomas of the pars intermedia have been reported to have multiple endocrinopathies, including thyroid adenomas and parathyroid h y p e r p l a~i a .~~.~~ Except for two horses with concurrent pheochromocytomas and two horses with thyroid adenomas in this study, there was no evidence of multiple endocrine neoplasia as described in human being^^,^^,^^ and the rat.7J3s30
The mechanisms responsible for the development of pars intermedia-adenomas and multinodular corticotroph hyperplasia in the pars distalis of older horses a-MSH. and the clinical significance of the latter are unknown. Corticotroph hyperplasia in the pars distalis has been reported infrequently in cases of canine24 and human Cushing's disease or w i t h o~t '~,~~ ectopic secretion of corticotropin-releasing factor. The development of pituitary adenomas resulting in pituitarydependent Cushing's disease in human beings14 is believed to be preceded by corticotroph hyperplasia secondary to stimulation by hypothalamic factor@) including corticotropin-releasing hormone.I2 Proliferation of corticotrophs in the pars distalis without adenoma formation has been reported in the rat following chronic administration of corticotropin-releasing fac-Corticotrophs ofthe pars distalis are under stimulatory neurohormonal control of hypothalamic corticotropin-releasing hormone,2s whereas the secretory activity of corticotrophs in the normal pars intermedia is regulated predominantly via dopaminergic inhibitory mechanism^.^,^^ There is evidence, however, that in rodents corticotropin-releasing hormone stimulates release of a-MSH and ACTH from the pars intermedia.26 Peptide secretion by pituitary adenomas has been reported to be extremely resistant to glucocorticoids but sensitive to dopaminergic agonists in the horse. 21 
